DeepMed Research

Oregon Health and Science University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Clinical Trial of Infliximab for Uveitis

Not Applicable

Completed

Conditions: Uveitis

First Posted Date: 2006-01-09

Last Posted Date: 2011-07-04

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 32

Registration Number: NCT00273390

Measuring Preferences for Childbirth After Cesarean

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Behavioral: Use of Computerized Decision Aid on Childbirth

First Posted Date: 2005-12-21

Last Posted Date: 2019-12-11

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 131

Registration Number: NCT00267735

Locations: 🇺🇸
Oregon Health & Science University Clinics, Portland, Oregon, United States

Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency

Terminated

Conditions: Mevalonate Kinase Deficiency
Immune System Diseases
Lipid Metabolism, Inborn Errors
Periodic Fever Syndromes, Hereditary
Mevalonic Aciduria

First Posted Date: 2005-12-01

Last Posted Date: 2019-05-24

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 1

Registration Number: NCT00260299

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Medications for the Treatment of Dysthymic Disorder and Double Depression

Phase 4

Completed

Conditions: Depression
Dysthymia

First Posted Date: 2005-10-06

Last Posted Date: 2019-07-29

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 40

Registration Number: NCT00234312

Locations: 🇺🇸
Oregon Health Sciences University, Portland, Oregon, United States

Effectiveness of Supplemental Calcium in Preventing Postpartum Depression

Phase 4

Completed

Conditions: Depression
Depression, Postpartum

First Posted Date: 2005-09-28

Last Posted Date: 2014-03-20

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 238

Registration Number: NCT00228033

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Efalizumab for Moderate to Severe Atopic Dermatitis

Phase 1

Completed

Conditions: Dermatitis, Atopic

Interventions: Drug: Raptiva

First Posted Date: 2005-09-26

Last Posted Date: 2020-01-03

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 10

Registration Number: NCT00226057

Pilot Trial of a Behavioral Treatment for Epilepsy

Phase 1

Completed

Conditions: Epilepsies, Partial

Interventions: Behavioral: Andrews/Reiter behavioral treatment for epilepsy

First Posted Date: 2005-09-21

Last Posted Date: 2019-08-01

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 8

Registration Number: NCT00212745

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood

Phase 4

Completed

Conditions: Kidney Failure, Chronic
Growth Hormone Deficiency

Interventions: Drug: Nutropin AQ

First Posted Date: 2005-09-21

Last Posted Date: 2011-10-26

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 17

Registration Number: NCT00212758

Locations: 🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
University of California in Los Angeles (UCLA), Los Angeles, California, United States

and more 5 locations

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta

Phase 4

Completed

Conditions: Osteogenesis Imperfecta

Interventions: Drug: Teriparatide (FORTEO)
Drug: Placebos

First Posted Date: 2005-08-18

Last Posted Date: 2019-04-24

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 79

Registration Number: NCT00131469

Locations: 🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States
🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸
Baylor College of Medicine, Department of Molecular and Human Gentics, Houston, Texas, United States

Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome

Not Applicable

Completed

Conditions: Metabolic Syndrome X
Prediabetic State
Insulin Resistance
Metabolic Diseases
Obesity

Interventions: Drug: Dietary supplement for weight loss
Behavioral: Education and counseling for weight loss

First Posted Date: 2005-08-12

Last Posted Date: 2014-10-29

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 79

Registration Number: NCT00129792

Locations: 🇺🇸
Oregon Health and Science University General Clinical Research Center, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy